ATE375399T1 - Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane - Google Patents

Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane

Info

Publication number
ATE375399T1
ATE375399T1 AT98908909T AT98908909T ATE375399T1 AT E375399 T1 ATE375399 T1 AT E375399T1 AT 98908909 T AT98908909 T AT 98908909T AT 98908909 T AT98908909 T AT 98908909T AT E375399 T1 ATE375399 T1 AT E375399T1
Authority
AT
Austria
Prior art keywords
isolation
tissue
specific peptide
peptide ligands
target organs
Prior art date
Application number
AT98908909T
Other languages
English (en)
Inventor
Amos Panet
Yocheved Hagai
Janette Lazarovits
Abraham Nimrod
Tikva Vogel
Avigdor Levanon
Elisha Zeelon
Anna Belkind
Itshak Golan
Original Assignee
Savient Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Savient Pharmaceuticals Inc filed Critical Savient Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE375399T1 publication Critical patent/ATE375399T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98908909T 1997-03-04 1998-03-04 Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane ATE375399T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3950997P 1997-03-04 1997-03-04
US81007497A 1997-03-04 1997-03-04

Publications (1)

Publication Number Publication Date
ATE375399T1 true ATE375399T1 (de) 2007-10-15

Family

ID=26716199

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98908909T ATE375399T1 (de) 1997-03-04 1998-03-04 Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane

Country Status (7)

Country Link
EP (1) EP0975792B1 (de)
AT (1) ATE375399T1 (de)
AU (1) AU6682598A (de)
CA (1) CA2283474A1 (de)
DE (1) DE69838544T2 (de)
IL (1) IL131655A0 (de)
WO (1) WO1998039469A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708265D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
EP1167382A1 (de) * 1999-03-31 2002-01-02 Otsuka Pharmaceutical Co., Ltd. Sich an das hämagglutinin des influenzavirus bindendes peptid
GB9912994D0 (en) * 1999-06-07 1999-08-04 Melvin William T Fibrin fragments and therapeutic targets
US6903196B1 (en) 1999-06-17 2005-06-07 Utah Ventures Ii, L.P. Methods for identifying and isolating tissue-specific lumen-exposed molecules
CA2399058A1 (en) * 2000-02-02 2001-08-09 Transgene S.A. Targeting peptides
SK6312002A3 (en) * 2000-09-04 2002-09-10 Hyo-Joon Kim Mimetic peptides for epitope of apolipoprotein b-110, concatemer and modified peptides thereof, and the vaccine composition comprising the same
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
EP1497314A4 (de) * 2001-09-07 2007-10-10 Univ Texas Auf peptide gegen plazenta- und fettgewebe abzielende zusammensetzungen und verwendungsverfahren
WO2004060403A2 (en) 2003-01-06 2004-07-22 Angiochem Inc. Aprotinin and anglos as carriers across the blood-brain barrier
JP2006101709A (ja) * 2004-09-30 2006-04-20 Glycomedics Inc ヘマグルチニン結合ペプチド、インフルエンザウイルス感染阻害剤、リポソーム、インフルエンザ治療薬、インフルエンザ予防薬
RU2408605C2 (ru) 2005-02-18 2011-01-10 Анджиокем Инк. Полипептид, способный преодолевать гематоэнцефалический барьер, и его конъюгат
ES2744225T3 (es) 2005-07-15 2020-02-24 Angiochem Inc Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
MX355683B (es) 2008-04-18 2018-04-26 Angiochem Inc Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel, y métodos relacionados de preparación y uso.
CA2740316A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
WO2010043049A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
CA2745524C (en) 2008-12-05 2020-06-09 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
US8853353B2 (en) 2008-12-17 2014-10-07 Angiochem, Inc. Membrane type-1 matrix metalloprotein inhibitors and uses thereof
MX2011011023A (es) 2009-04-20 2012-01-20 Angiochem Inc Tratamiento de cancer de ovarios usando un agente anti-cancer conjugado con un analogo de angiopep-2.
RU2012103240A (ru) 2009-07-02 2013-08-10 Ангиокем Инк. Мультимерные пептидные конъюгаты и их применение
JP2015526434A (ja) 2012-08-14 2015-09-10 アンジオケム インコーポレーテッド ペプチド−デンドリマーコンジュゲート及びその使用
EP3307326B9 (de) 2015-06-15 2021-02-24 Angiochem Inc. Verfahren zur behandlung von leptomeningealer karzinomatose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
WO1994026787A1 (en) * 1993-05-07 1994-11-24 The Board Of Trustees Of The Leland Stanford Junior University Method for generating cell type specific phage antibody libraries
JP3900305B2 (ja) * 1995-09-11 2007-04-04 ザ バーナム インスティテュート インビボにおいて選択された器官または組織に帰巣する分子および同分子を同定する方法

Also Published As

Publication number Publication date
DE69838544D1 (de) 2007-11-22
EP0975792A4 (de) 2002-12-04
AU6682598A (en) 1998-09-22
WO1998039469A1 (en) 1998-09-11
CA2283474A1 (en) 1998-09-11
EP0975792B1 (de) 2007-10-10
IL131655A0 (en) 2001-01-28
HK1026234A1 (en) 2000-12-08
EP0975792A1 (de) 2000-02-02
DE69838544T2 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
ATE375399T1 (de) Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane
DE69533855D1 (de) UNTERBRECHUNG DER BINDUNG DER PROTEINE MDM2 UND p53 UND ENTSPRECHENDE THERAPEUTISCHE ANWENDUNG
DE60025832D1 (de) Mehrere zytokin-antikörper komplexen
DE69534309D1 (de) Medizinische verwendung von matrixmetallproteine-inhibitoren zur hemmung von gewebekontraktion
NO962991L (no) Zink-finger-proteinderivater og fremgangsmåter derav
ATE407205T1 (de) Verbesserung in bezug auf bindungsproteine bei der erkennung von dna
DE60040060D1 (de) Kontrolle des proteinspiegels in eukaryotischen organismen
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
FI925986A0 (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
WO2005035551A3 (en) Inhibitors of proteins that bind phosphorylated molecules
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
DK1650219T3 (da) Humane TOLL-homologer
ATE342067T1 (de) Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon
ATE290315T1 (de) Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits
ATE300619T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
CA2200855A1 (en) Radioactive phosphorous labeling of proteins for targeted radiotherapy
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
DE69738761D1 (de) Wechselwirkungen der katalytischen untereinheit der proteinphosphatase 1
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
DE19881583D2 (de) Verfahren und Kit zur Identifizierung von Wechselwirkungen zwischen Proteinen bzw. Peptiden
DE69839733D1 (de) Mit syndekan interagierende proteine und deren verwendung
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
NO20023914L (no) Preparater for anvendelse for regulering av aktiviteten til parkingenet
UA88604C2 (ru) Применение антитела, которое связывается с альфа-4-интегрином, для лечения демиелинизирующего заболевания

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties